Respiratory Infections News

Pfizer and BioNTech reported that their COVID-19 vaccine is around 90% effective against symptomatic illness in children aged 5 to 11 years with no serious safety concerns, according to a document published Friday by the FDA.

A CDC advisory committee on Thursday unanimously recommended booster doses of the COVID-19 vaccines made by Moderna and Johnson & Johnson, aligning with an FDA authorization issued this week.

Pfizer and BioNTech said Thursday that a booster dose of their COVID-19 vaccine was safe and demonstrated a relative efficacy of more than 95% compared with not receiving a booster shot, according to findings from a phase 3 trial.

Children with an inflammatory syndrome linked to SARS-CoV-2 infection mount a normal T-cell response to the virus, according results from a multi-institutional study ­­reported in the European Journal of Immunology.

As the COVID-19 pandemic progresses, the emergence of more transmissible variants has coincided with an increase in the proportion of U.S. cases reported among children.

The deviation of many respiratory viral infections from a seasonal cadence is all too real.

I never had any intention of pursuing a career in infectious diseases — or medicine for that matter.

The FDA on Wednesday said it is OK for Americans to choose a different COVID-19 vaccine for their booster shot.

The CDC’s Advisory Committee on Immunization Practices made new recommendations Wednesday for adult pneumococcal and herpes zoster vaccination.

U.S. counties with the strongest primary care and public health infrastructures and social assets had the fewest SARS-COV-2 infections and related deaths, according to a report from the Primary Care Collaborative and Robert Graham Center.